Paydirt
FATE
Ticker

Fate Therapeutics, Inc.

FATE · Healthcare · Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune dis…

Fate Therapeutics, Inc. (FATE), in the Healthcare sector, has 1 disclosed filing on Paydirt over the trailing twelve months from 1 corporate insider: 0 purchases and 1 sale. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Aug 4 and filed Aug 5. The most active filer was Bahram Valamehr with 1 filing. Data as of Nov 8 2026.

Add to watchlist
Filings, ttm
1
0 buys · 1 sell
Traders, ttm
1
1 insider
Volume, ttmiDollar value disclosed in the window
$108K
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Aug 4
Filed Aug 5
ADViAverage daily dollar volume
$9.7M
market data
Share price · 12M
$2.62 (+140.4%)
$3.11$2.03$0.96Nov 10 2025Mar 25Aug 5

Adjusted for splits and dividends.

Volume by month
$669K$334K$0Dec 2024Jun 2025Dec 2025Jun 2026Dec 2024 · buys $669KDec 2024 · sells $574KAug 2026 · sells $108K
Buys $669K Sells $682K

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
JG Jeremy Green Director 1 filing · 1 buy, 1 sale BV Bahram Valamehr President and CEO 1 filing · 0 buys, 1 sale
Recent filings
Bahram ValamehrSALE President and CEO $108K
43,947 sh × $2.46
Exec Aug 4
Filed Aug 5 · 4:01 PM ET Jeremy GreenSALE Director $574K
341,633 sh × $1.68
Exec Dec 20 2024
Filed Dec 26 2024 · 5:30 PM ET † Jeremy GreenPURCHASE Director $669K
397,964 sh × $1.68
Exec Dec 20 2024
Filed Dec 26 2024 · 5:30 PM ET †